13F filer · CIK 1848809
Velan Capital Investment Management LP
ALPHARETTA, GA · filing since Q4 2021 · last filing Aug 14, 2026
Reported value
$164.2M
+$4.6M vs prior
Positions
51
New / sold out
7 / 5
Added / reduced
10 / 11
Turnover
9.2%
buys $14.9M · sells $18.8M
Top-10 weight
74.8%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | IMMIX BIOPHARMA INC | +345,000 | +46.6% | +$3.6M |
| New | C4 THERAPEUTICS INC | +570,000 | – | +$2.7M |
| Added | AVALO THERAPEUTICS INC | +139,330 | +75.3% | +$2.6M |
| New | ADMA BIOLOGICS INC | +250,000 | – | +$2.1M |
| New | REIN THERAPEUTICS INC | +1,700,000 | – | +$1.8M |
| New | TENAX THERAPEUTICS INCCALL | +68,700 | – | +$999.6K |
| Added | NEUMORA THERAPEUTICS INC. | +150,000 | +187.5% | +$255.0K |
| New | TECTONIC THERAPEUTIC INC | +6,000 | – | +$206.3K |
| New | AN2 THERAPEUTICS INC | +40,000 | – | +$193.6K |
| New | SCYNEXIS INC | +40,000 | – | +$162.8K |
7 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ESPERION THERAPEUTICS INC NE | -1,720,000 | -100.0% | $-4.7M |
| Reduced | PRAXIS PRECISION MEDICINES I | -12,000 | -11.9% | $-4.0M |
| Reduced | CYTOMX THERAPEUTICS INC. | -420,000 | -77.8% | $-1.6M |
| Reduced | ABIVAX SA | -11,370 | -14.8% | $-1.5M |
| Reduced | VIRIDIAN THERAPEUTICS INC | -81,123 | -89.0% | $-1.5M |
| Reduced | INSPIREMD INC | -1,951,514 | -92.9% | $-1.4M |
| Sold out | KAZIA THERAPEUTICS LTD | -135,315 | -100.0% | $-1.0M |
| Reduced | ROCKET PHARMACEUTICALS INC | -234,643 | -79.6% | $-802.5K |
| Reduced | PROFOUND MED CORP | -115,432 | -40.4% | $-767.6K |
| Reduced | TENAX THERAPEUTICS INC | -33,348 | -5.7% | $-485.2K |
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES ICOM NEW | 88,781 | $29.7M | 18.10% |
| 2 | MAPLIGHT THERAPEUTICS INCCOM | 492,893 | $17.7M | 10.76% |
| 3 | SUTRO BIOPHARMA INCCOM SHS | 512,160 | $17.0M | 10.36% |
| 4 | IMMIX BIOPHARMA INCCOM | 1,085,000 | $11.2M | 6.81% |
| 5 | PROTARA THERAPEUTICS INCCOM STK | 2,844,652 | $10.9M | 6.62% |
| 6 | ABIVAX SASPONSORED ADS | 65,630 | $8.7M | 5.33% |
| 7 | TENAX THERAPEUTICS INCCOM NEW | 549,985 | $8.0M | 4.87% |
| 8 | ANTERIS TECHNOLOGIES GLOBALCOM | 700,000 | $6.9M | 4.20% |
| 9 | EDESA BIOTECH INCCOM NEW | 827,500 | $6.7M | 4.10% |
| 10 | EVOMMUNE INCCOM SHS | 451,255 | $6.0M | 3.65% |
41 more rows. Subscribe for $29/month to see every row, download the data and use the API.